| Dr Christopher Jamarl Watts, MD | |
|
6043 Prestley Mill Rd, Suite C, Douglasville, GA 30134 | |
| (770) 920-3076 | |
| (770) 949-8969 |
| Full Name | Dr Christopher Jamarl Watts |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 21 Years |
| Location | 6043 Prestley Mill Rd, Douglasville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194884916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 49441 (Wisconsin) | Secondary |
| 207RI0200X | Internal Medicine - Infectious Disease | 061182 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Wellstar Cobb Hospital | Austell, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.
When adolescents graduate to young adulthood, their preventive care tends to fall by the wayside. A recent study has found that young adults are much less likely to use ambulatory or preventive care, even though their mortality rate is more than twice that of adolescents.
States serve as "laboratories of democracy," as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.
› Verified 2 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.
When adolescents graduate to young adulthood, their preventive care tends to fall by the wayside. A recent study has found that young adults are much less likely to use ambulatory or preventive care, even though their mortality rate is more than twice that of adolescents.
States serve as "laboratories of democracy," as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.
› Verified 2 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.
When adolescents graduate to young adulthood, their preventive care tends to fall by the wayside. A recent study has found that young adults are much less likely to use ambulatory or preventive care, even though their mortality rate is more than twice that of adolescents.
States serve as "laboratories of democracy," as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Jamarl Watts, MD 6043 Prestley Mill Rd, Suite C, Douglasville, GA 30134-2280 Ph: (770) 920-3076 | Dr Christopher Jamarl Watts, MD 6043 Prestley Mill Rd, Suite C, Douglasville, GA 30134 Ph: (770) 920-3076 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Critical Diagnostics, the exclusive developer of the Presage® ST2 Assay, announces the publication of the Penn Heart Failure Study (PHFS) in an advance e-publication of the January 19, 2010 edition of Circulation: Heart Failure. The results of this study demonstrated that ST2 levels not only predict outcomes for ambulatory outpatients with chronic heart failure, they more effectively risk-stratify such patients.
When adolescents graduate to young adulthood, their preventive care tends to fall by the wayside. A recent study has found that young adults are much less likely to use ambulatory or preventive care, even though their mortality rate is more than twice that of adolescents.
States serve as "laboratories of democracy," as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.
› Verified 2 days ago
Safal Shetty, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2020, Douglasville, GA 30134 Phone: 770-422-1372 | |
Michael B Piansky, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6043 Prestley Mill Rd Ste B, Douglasville, GA 30134 Phone: 770-941-8100 Fax: 678-945-9331 | |
Navinchandra M Ruparelia, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 4904 Timber Ridge Dr, Suite 202a, Douglasville, GA 30135 Phone: 770-949-6548 Fax: 770-949-9561 | |
Dr. Gray Akoegbe, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6001 Professional Pkwy Ste 2080, Douglasville, GA 30134 Phone: 678-715-5080 | |
Neal K Osborn, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr, Suite 101, Douglasville, GA 30134 Phone: 678-784-5020 Fax: 678-784-5024 | |
Dr. Kathryn Amanda Mcfarland, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8687 Hospital Dr Ste 102, Douglasville, GA 30134 Phone: 678-785-5001 Fax: 888-464-0963 | |
Dr. Nana Abena Arthur, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8954 Hosptial Drive, Wellstar Health System Douglas Hospital, Douglasville, GA 30134 Phone: 678-838-2585 |